Two Sigma Securities’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.9K Buy
+10,177
New +$55.9K 0.01% 1365
2022
Q2
Sell
-1,084
Closed -$9K 2157
2022
Q1
$9K Buy
+1,084
New +$7.44K ﹤0.01% 2048

Other funds holding ABEO

Two Sigma Securities's ABEO Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Abeona Therapeutics (ABEO) in Q2 2026: 10,177 shares worth $62.9K. The stake represents 0.01% of the portfolio and ranks #1365 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ABEO as recently as Q1 2022.

Two Sigma Securities first reported a position in ABEO in Q1 2022 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Two Sigma Securities held 10,177 shares of Abeona Therapeutics worth $62.9K as of Q2 2026.
  • Abeona Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • Abeona Therapeutics made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1365 holding.
  • Two Sigma Securities first reported a position in Abeona Therapeutics in Q1 2022 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.